FIC Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $17.7M | Sell |
150,676
-19,653
| -12% | -$2.31M | 6.75% | 2 |
|
|
2017
Q2 | $13.6M | Sell |
170,329
-1,783
| -1% | -$142K | 5.59% | 2 |
|
|
2017
Q1 | $8.82M | Sell |
172,112
-130
| -0.1% | -$6.66K | 3.91% | 4 |
|
|
2016
Q4 | $6.45M | Buy |
172,242
+4,902
| +3% | +$184K | 3.25% | 4 |
|
|
2016
Q3 | $11.3M | Sell |
167,340
-2,208
| -1% | -$150K | 5.09% | 2 |
|
|
2016
Q2 | $9.41M | Buy |
169,548
+410
| +0.2% | +$22.8K | 4.45% | 2 |
|
|
2016
Q1 | $10.6M | Buy |
169,138
+4,432
| +3% | +$278K | 5.14% | 2 |
|
|
2015
Q4 | $15.5M | Buy |
164,706
+2,589
| +2% | +$244K | 6.87% | 1 |
|
|
2015
Q3 | $13M | Buy |
162,117
+6,435
| +4% | +$517K | 6.12% | 1 |
|
|
2015
Q2 | $18.7M | Sell |
155,682
-4,350
| -3% | -$521K | 7.41% | 1 |
|
|
2015
Q1 | $16.7M | Buy |
160,032
+850
| +0.5% | +$88.8K | 6.36% | 1 |
|
|
2014
Q4 | $15.4M | Buy |
159,182
+1,650
| +1% | +$160K | 5.98% | 1 |
|
|
2014
Q3 | $12.3M | Buy |
157,532
+5,060
| +3% | +$395K | 4.92% | 1 |
|
|
2014
Q2 | $9.63M | Buy |
152,472
+14,684
| +11% | +$928K | 3.75% | 3 |
|
|
2014
Q1 | $9.25M | Buy |
137,788
+13,230
| +11% | +$888K | 3.78% | 2 |
|
|
2013
Q4 | $8.01M | Buy |
124,558
+8,365
| +7% | +$538K | 3.59% | 3 |
|
|
2013
Q3 | $7.44M | Buy |
116,193
+12,975
| +13% | +$831K | 3.78% | 1 |
|
|
2013
Q2 | $3.2M | Buy |
+103,218
| New | +$3.2M | 2.05% | 10 |
|